Age of diagnosis, tumor size, and survival after breast cancer: implications for mammographic screeningNAROD, Steven A.Breast cancer research and treatment. 2011, Vol 128, Num 1, pp 259-266, issn 0167-6806, 8 p.Article

The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancerNAROD, Steven A.Breast cancer research and treatment. 2011, Vol 128, Num 2, pp 581-583, issn 0167-6806, 3 p.Article

Androgens and breast cancerKOTSOPOULOS, Joanne; NAROD, Steven A.Steroids. 2012, Vol 77, Num 1-2, pp 1-9, issn 0039-128X, 9 p.Article

Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A reviewFINCH, Amy; NAROD, Steven A.Maturitas (Amsterdam). 2011, Vol 70, Num 3, pp 261-265, issn 0378-5122, 5 p.Article

Ovarian cancer and hormone replacement therapy in the Million Women Study. CommentaryNAROD, Steven A; WOMEN, Million.Lancet (British edition). 2007, Vol 369, Num 9574, issn 0140-6736, 1667-1668,1703-1710 [10 p.]Article

Multiple primary cancers as a guide to heritabilityCYBULSKI, Cezary; NAZARALI, Safia; NAROD, Steven A et al.International journal of cancer (Print). 2014, Vol 135, Num 8, pp 1756-1763, issn 0020-7136, 8 p.Article

Breast cancer risk perception among Women who have undergone Prophylactic bilateral mastectomyMETCALFE, Kelly A; NAROD, Steven A.Journal of the National Cancer Institute. 2002, Vol 94, Num 20, pp 1564-1569, issn 0027-8874, 6 p.Article

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literatureLIEDE, Alexander; KARLAN, Beth Y; NAROD, Steven A et al.Journal of clinical oncology. 2004, Vol 22, Num 4, pp 735-742, issn 0732-183X, 8 p.Article

Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: A descriptive studyMETCALFE, Kelly A; SEMPLE, John L; NAROD, Steven A et al.Plastic and reconstructive surgery (1963). 2004, Vol 114, Num 2, pp 360-366, issn 0032-1052, 7 p.Article

Analysis of BRCA1 and BRCA2 mutations in an iranian family with hereditary breast and ovarian cancer syndromeMOSLEHI, Roxana; HASSAN KARIMINEJAD, M; GHAFFARI, Vahraz et al.American journal of medical genetics. 2003, Vol 117A, Num 3, pp 304-305, issn 0148-7299, 2 p.Article

Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversityGHADIRIAN, Parviz; NAROD, Steven; FAFARD, Eve et al.Breast cancer research and treatment. 2009, Vol 117, Num 2, pp 417-422, issn 0167-6806, 6 p.Article

A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25HUNG, Rayjean J; MCKAY, James D; FABIANOVA, Eleonora et al.Nature (London). 2008, Vol 452, Num 7187, pp 633-637, issn 0028-0836, 5 p.Article

Ovarian Cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 MutationsSATAGOPAN, Jaya M; BOYD, Jeff; KAUFF, Noah D et al.Clinical cancer research. 2002, Vol 8, Num 12, pp 3776-3781, issn 1078-0432, 6 p.Article

Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancerAKBARI, Mohammad R; ANDERSON, Laura N; GALLINGER, Steven et al.Cancer epidemiology (Print). 2013, Vol 37, Num 4, pp 424-427, issn 1877-7821, 4 p.Article

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant ChemotherapyBYRSKI, Tomasz; GRONWALD, Jacek; DENT, Rebecca et al.Journal of clinical oncology. 2010, Vol 28, Num 3, pp 375-379, issn 0732-183X, 5 p.Article

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2HONGLIN SONG; RAMUS, Susan J; DÖRK, Thilo et al.Nature genetics. 2009, Vol 41, Num 9, pp 996-1000, issn 1061-4036, 5 p.Article

Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?CHARAMES, George S; MILLAR, Anna L; PAL, Tuya et al.Human genetics. 2000, Vol 107, Num 6, pp 623-629, issn 0340-6717Article

Randomized Controlled Trial of a Psychosocial Telephone Counseling Intervention in BRCA1 and BRCA2 Mutation CarriersGRAVES, Kristi D; WENZEL, Lari; BARNES, Denise et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 3, pp 648-654, issn 1055-9965, 7 p.Article

A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutationsESPLEN, Mary Jane; HUNTER, Jon; KIEFFER, Stephanie et al.Cancer. 2004, Vol 101, Num 10, pp 2327-2340, issn 0008-543X, 14 p.Article

Factors influencing arm and axillary symptoms after treatment for node negative breast carcinomaYAP, Karen P. L; MCCREADY, David R; NAROD, Steven et al.Cancer. 2003, Vol 97, Num 6, pp 1369-1375, issn 0008-543X, 7 p.Article

A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancerJAKUBOWSKA, Anna; SCOTT, Rodney; STARZYNSKA, Teresa et al.European journal of human genetics. 2003, Vol 11, Num 12, pp 955-958, issn 1018-4813, 4 p.Article

Sampling Strategies for Tissue Microarrays to Evaluate Biomarkers in Ovarian CancerPERMUTH-WEY, Jenny; BOULWARE, David; COPPOLA, Domenico et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 1, pp 28-34, issn 1055-9965, 7 p.Article

Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patientsRASHID, Muhammad U; ZAIDI, Anbreen; AMIN, Asim et al.International journal of cancer. 2006, Vol 119, Num 12, pp 2832-2839, issn 0020-7136, 8 p.Article

Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutationsHALBERT, Chanita Hughes; WENZEL, Lari; LERMAN, Caryn et al.Cancer epidemiology, biomarkers & prevention. 2004, Vol 13, Num 5, pp 875-881, issn 1055-9965, 7 p.Article

BRCA1 promoter region hypermethylation in ovarian carcinoma : A population-based studyBALDWIN, Rae Lynn; NEMETH, Elizabeta; HANG TRAN et al.Cancer research (Baltimore). 2000, Vol 60, Num 19, pp 5329-5333, issn 0008-5472Article